本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Amylyx Pharmaceuticals

15.05
+0.94006.66%
盤前15.140.0900+0.60%05:32 EST
成交量:145.71萬
成交額:2,166.04萬
市值:16.64億
市盈率:-9.83
高:15.25
開:14.07
低:13.92
收:14.11
52周最高:17.49
52周最低:2.60
股本:1.11億
流通股本:6,544.94萬
量比:1.21
換手率:2.23%
股息:- -
股息率:- -
每股收益(TTM):-1.5305
每股收益(LYR):-1.5305
淨資產收益率:-61.59%
總資產收益率:-36.41%
市淨率:5.45
市盈率(LYR):-9.83

資料載入中...

2026/03/03

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/03

重要事件披露

Form 8-K - Current report
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/08

重要事件披露

Form 8-K - Current report
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities